Leenate Pharma Pvt. Ltd
We are a leading Pharmaceutical Marketing Company having a wide range of Pharmaceutical and Nutraceutical products & have achieved this in a very short period which shows that we are a fast growing company.
We dedicate ourselves to the high ethical standards.
We discover new potential, making the most of our ingenuity.
We pursue individual growth, always pushing ourselves further.
We act as a team, developing ties of mutual trust and respect.
An ISO 9001:2008 Certified Company, Tieups with WHO-GMP Ceritified manufacturers.
We have a spacious and well-equipped infrastructural-unit which enhances our work output. It enables us to serve the customer`s bulk demands.
Our Product Gallery
What We Offer
Leenate Pharma, engaged in manufacturing of effective Pharmaceutical products manufacturers , Backed by an extensive experience, coupled with sophisticated Pharma professionals and skilled team, we have established ourselves as a trusted name in the Pharmaceutical industry, globally.
To lead in adapting technology for building fast, high-quality information architectures by researching real-world health challenges. It’s about doing things differently.
Helping Make People Life Healthier!
We believe we will be ONLY successful when we able to create some value addition for our clients and end users. We are a values driven organization. Our values reflect the thinking of our founder, Mr. Gurjot Singh.
Identify | Develop | Expand
These are the THREE key elements of our strategy. We offer complete integration in value transformation. The Company is continually evaluating new opportunities for development of Pharmaceutical products manufacturers , whether by exploring new potential markets to expand and serve people. Our sales and marketing efforts are focused on expanding our reach across the globe and keeping healthcare providers informed of how our products are able to improve the quality of care for their patients. The combination of our ongoing development activities and marketing efforts drives the success of our products.
Denmark’s Xellia Pharmaceuticals has bought the former Ben Venue plant, at one time the most notorious U.S. plant under FDA supervision, and the facility responsible for dozens of recalls and a slew of drug shortages.
Turing Pharmaceutical products manufacturers has been saying for a while now that it would lower the price of its toxoplasmosis med, Daraprim, responding to growing backlash from lawmakers and the public after it bought the drug in August